1. Medtech Insight
  2. >>Device Area
  3. >>Surgery
  4. >>Robotic Surgery

J&J Medtech’s FDA-Cleared DUALTO System Prepares For Future Use With OTTAVA Robotic Platform

Future-Ready Surgical Energy Platform Designed For Flexibility, Precision And Robotic Integration

 
• By Shubham Singh

DUALTO’s double-module option provides enhanced flexibility while cutting down on equipment clutter. Compared to traditional setups, the system reduces OR footprint by 46%, helping staff reclaim space and optimize surgical workflows.

Designed to consolidate multiple energy modalities into a single platform, DUALTO also incorporates connectivity features and modular configurations that support broader digital integration.
Key Takeaways
  • DUALTO is FDA-cleared to consolidate four energy modalities into one system, with a modular, dual-surgeon configuration and a single touchscreen interface for streamlined workflows. 

      J&J MedTech’s DUALTO Energy System, recently cleared by the FDA, is not only built to replace multiple legacy generators–it’s also...

      Read the full article – start your free trial today!

      Join thousands of industry professionals who rely on Medtech Insight for daily insights

      • Start your 7-day free trial
      • Explore trusted news, analysis, and insights
      • Access comprehensive global coverage
      • Enjoy instant access – no credit card required
      Start Free Trial

      Already a subscriber?

      More from Robotic Surgery

      Johnson & Johnson MedTech: How To Scale Digital Solutions

       
      • By Natasha Barrow

      J&J's EMEA head of digital solutions, Julia Fishman, talks about the major hurdles in scaling digital innovation, tips for clinical adoption and what’s up next on J&J’s innovation road map. Robot-assisted surgery pioneer Ivo Broeders gives his perspective on the difficulties in clinical adoption.

      SS Innovations Files For De Novo For SSi Mantra 3 Surgical Robotic System For Multispecialty Indications

       
      • By Marion Webb

      SS Innovations announced plans to file a de novo application with the US FDA for its SSi Mantra 3 surgical robot, already approved for marketing in six countries. The Florida-based firm also plans to pursue the CE mark for European commercialization.

      AAOS 2025 Orthopedic Roundup: J&J Velys UKA, Stryker Mako 4, Materialise, Canary Medical

       
      • By Marion Webb

      At AAOS, orthopedics players showcased their latest robotic-assisted platforms, power tools, 3D printed technologies and software offerings. This article brings you highlights from interviews Medtech Insight conducted on site with representatives from J&J, Stryker, Materialise and Canary Medical.

      Medtronic Presents Data To Boost Hugo’s Odds Of Getting FDA Nod

       
      • By Brian Bossetta

      Medtronic says results from a recent study on the Hugo robotic-assisted surgery system substantiate its safety and effectiveness for various urological procedures. The company also announced it has submitted the system to the FDA for approval for a urological indication.

      More from Medtech Insight

      Panel: FDA’s Home Healthcare Initiative Holds Promise, But Challenges Remain

       
      • By Elizabeth Orr

      During a recent FDLI panel, experts discussed the FDA's Home Healthcare initiative, highlighting its potential benefits and challenges. Key issues include usability testing, reimbursement, labeling for home use, and the need for innovation while ensuring patient safety.

      Execs On The Move: 26-30 May 2025

       
      • By Medtech Insight Team

      An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

      Where Do Questions Surrounding The EU’s AI Act Leave The Medtech Industry?

       
      • By Amanda Maxwell

      The EU’s Artificial Intelligence Act, which entered into force on 1 August 2024, is already facing turbulence.